Search Results - "EHLHARDT, W. J"
-
1
Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979
Published in Cancer research (Chicago, Ill.) (15-09-1996)“…Overexpression of P-glycoprotein (Pgp) by tumors results in multidrug resistance (MDR) to structurally unrelated oncolytics. MDR cells may be sensitized to…”
Get full text
Journal Article -
2
Sulfonimidamide analogs of oncolytic sulfonylureas
Published in Journal of medicinal chemistry (14-03-1997)“…A series of sulfonimidamide analogs of the oncolytic diarylsulfonylureas was synthesized and evaluated for (1) in vitro cytotoxicity against CEM cells, (2) in…”
Get full text
Journal Article -
3
Metabolism and Disposition of the Antifolate LY231514 in Mice and Dogs
Published in Drug metabolism and disposition (01-06-1997)“…The metabolism and disposition of LY231514 was studied in mice and dogs. LY231514 is a novel pyrrolopyrimidine-based multi-target antifolate (MTA) showing…”
Get full text
Journal Article -
4
Metabolism and disposition of the anticancer agent sulofenur in mouse, rat, monkey, and human
Published in Drug metabolism and disposition (01-03-1991)“…The elimination and metabolism of sulofenur [N-(5-indanesulfonyl)-N'-(4-chlorophenyl)urea, LY186641] was examined in mice, rats, monkeys, and humans. The…”
Get more information
Journal Article -
5
Metabolism and disposition of p-chloroaniline in rat, mouse, and monkey
Published in Drug metabolism and disposition (01-03-1991)“…The metabolism and disposition of [14C]p-chloroaniline was studied in the male Fisher 344 rat, female C3H mouse, and male rhesus monkey. Greater than 90% of…”
Get more information
Journal Article -
6
Liquid Chromatography/Nuclear Magnetic Resonance Spectroscopy and Liquid Chromatography/Mass Spectrometry Identification of Novel Metabolites of the Multidrug Resistance Modulator LY335979 in Rat Bile and Human Liver Microsomal Incubations
Published in Drug metabolism and disposition (01-01-1998)“…Compound LY335979 is a P-glycoprotein inhibitor currently entering phase I clinical trials for potential reversal of multidrug resistance to cancer…”
Get full text
Journal Article -
7
Characterization of an O-glucuronide metabolite of the CCK-B antagonist LY288513 and its plasma levels in mouse, rat, and dog
Published in Drug metabolism and disposition (01-09-1995)“…LY288513 [(4S,5R)-trans-N-(4-bromophenyl)-3-oxo-4,5-diphenyl-1- pyrazolidinecarboxamide] has been developed as a cholecystokinin-B antagonist for anxiolytic…”
Get more information
Journal Article -
8
Biotransformation of the antiviral agent 1,3,4-thiadiazol-2-ylcyanamide (LY217896) and characteristics of a mesoionic ribose metabolite
Published in Drug metabolism and disposition (01-01-1993)“…The biotransformation of the antiinfluenza agent 1,3,4-thiadiazol-2-ylcyanamide (LY217896, I) was studied. In addition to a urea metabolite (II) formed by…”
Get more information
Journal Article -
9
Disposition and metabolism of the Sulfonylurea Oncolytic Agent LY295501 in Mouse, Rat, and Monkey
Published in Drug metabolism and disposition (01-06-1997)“…The disposition and metabolism of LY295501 was studied in mice, rats, and monkeys. This novel diaryl sulfonylurea oncolytic agent is structurally related to…”
Get full text
Journal Article -
10
Formation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans
Published in Drug metabolism and disposition (01-11-1992)Get more information
Journal Article -
11
Metabolism of Capsaicin by Cytochrome P450 Produces Novel Dehydrogenated Metabolites and Decreases Cytotoxicity to Lung and Liver Cells
Published in Chemical research in toxicology (01-03-2003)“…Capsaicin is a common dietary constituent and a popular homeopathic treatment for chronic pain. Exposure to capsaicin has been shown to cause various…”
Get full text
Journal Article -
12
Thiol-mediated incorporation of radiolabel from 1-[14C]-methyl-4-phenyl-5-nitrosoimidazole into DNA. A model for the biological activity of 5-nitroimidazoles
Published in Biochemical pharmacology (01-04-1989)“…1-Methyl-4-phenyl-5-nitrosoimidazole (5NO), which has properties consistent with the biologically active form of a 5-nitroimidazole, was radiolabeled…”
Get more information
Journal Article -
13
Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas
Published in Chemical research in toxicology (01-09-1992)“…The metabolic formation of p-chloroaniline from the oncolytic agent sulofenur [N-(5-indanesulfonyl)-N'-(4-chlorophenyl)urea, LY186641,] and from similar…”
Get full text
Journal Article -
14
Pharmacokinetics of the anticancer agent sulofenur in mice, rats, monkeys, and dogs
Published in Journal of pharmaceutical sciences (01-07-1993)“…The absorption and pharmacokinetics of sulofenur [N-(indan-5-sulfonyl)-N'-(4-chlorophenyl)urea, LY186641] and its major metabolites were examined in mice,…”
Get more information
Journal Article -
15
Formation of an amino reduction product of metronidazole in bacterial cultures: lack of bactericidal activity
Published in Biochemical pharmacology (15-01-1987)“…To investigate whether the amino reduction product of metronidazole has antibacterial activity, 5-amino-1-beta-hydroxyethyl-2-methylimidazole (AMN) was…”
Get more information
Journal Article -
16
Glutathione-Dependent Metabolism of the Antitumor Agent Sulofenur. Evidence for the Formation of p-Chlorophenyl Isocyanate as a Reactive Intermediate
Published in Chemical research in toxicology (01-02-2002)“…The antitumor agent sulofenur (LY186641), which has shown promising activity against a wide range of cancers, causes hemolytic anemia and methemoglobinemia at…”
Get full text
Journal Article -
17
Mammalian cell toxicity and bacterial mutagenicity of nitrosoimidazoles
Published in Biochemical pharmacology (01-07-1988)“…It is currently believed that the biological activity of such therapeutic 5-nitroimidazoles as metronidazole is mediated by a short-lived, highly toxic species…”
Get more information
Journal Article -
18
Chemical and biological properties of acetyl derivatives of the hydroxylamino reduction products of metronidazole and dimetridazole
Published in Biochemical pharmacology (15-03-1987)“…Metronidazole and related 5-nitroimidazoles undergo reduction of their nitro group apparently to produce such reactive species as 5-hydroxylaminoimidazoles. To…”
Get more information
Journal Article -
19
Binding of the epoxide cryptophycin analog, LY355703 to albumin and its effect on in vitro antiproliferative activity
Published in Oncology reports (01-09-1998)“…Cryptophycin, isolated from the cyanobacterium Nostoc, is a cytotoxic dioxadiazacyclohexadecenetetrone which causes rapid depletion of microtubules in intact…”
Get more information
Journal Article -
20
Novel acid labile COL1 trityl-linked difluoronucleoside immunoconjugates: synthesis, characterization, and biological activity
Published in Bioconjugate chemistry (01-07-1996)“…LY207702 (1) is a difluorinated purine nucleoside that exhibits impressive antitumor activity in preclinical models. This agent, however, also possesses…”
Get full text
Journal Article